A detailed history of Putnam Investments LLC transactions in Dexcom Inc stock. As of the latest transaction made, Putnam Investments LLC holds 2,220,074 shares of DXCM stock, worth $177 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
2,220,074
Previous 2,479,102 10.45%
Holding current value
$177 Million
Previous $231 Million 19.1%
% of portfolio
0.38%
Previous 0.36%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$75.49 - $124.16 $19.6 Million - $32.2 Million
-259,028 Reduced 10.45%
2,220,074 $275 Million
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $37.5 Million - $60.2 Million
436,190 Added 21.35%
2,479,102 $231 Million
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $25.5 Million - $29.7 Million
226,508 Added 12.47%
2,042,912 $263 Million
Q1 2023

May 22, 2023

SELL
$104.0 - $122.92 $2.23 Million - $2.64 Million
-21,463 Reduced 1.17%
1,816,404 $211 Million
Q4 2022

Feb 14, 2023

SELL
$84.98 - $122.67 $12.1 Million - $17.5 Million
-142,295 Reduced 7.19%
1,837,867 $208 Million
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $3.13 Million - $3.86 Million
-40,938 Reduced 2.03%
1,980,162 $159 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $102 Million - $200 Million
1,503,702 Added 290.63%
2,021,100 $151 Million
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $12.5 Million - $17.2 Million
132,367 Added 34.38%
517,398 $265 Million
Q4 2021

Feb 14, 2022

SELL
$129.87 - $162.82 $6.03 Million - $7.57 Million
-46,468 Reduced 10.77%
385,031 $207 Million
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $8.9 Million - $11.9 Million
-83,367 Reduced 16.19%
431,499 $236 Million
Q2 2021

Aug 16, 2021

SELL
$80.99 - $107.93 $907,897 - $1.21 Million
-11,210 Reduced 2.13%
514,866 $220 Million
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $1.79 Million - $2.21 Million
21,062 Added 4.17%
526,076 $189 Million
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $4.98 Million - $6.67 Million
63,831 Added 14.47%
505,014 $187 Million
Q3 2020

Nov 16, 2020

BUY
$95.51 - $112.95 $3.93 Million - $4.64 Million
41,110 Added 10.28%
441,183 $182 Million
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $7.61 Million - $12.8 Million
121,458 Added 43.59%
400,073 $162 Million
Q1 2020

May 15, 2020

BUY
$47.79 - $75.63 $13.3 Million - $21.1 Million
278,615 New
278,615 $75 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.7B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.